ANIX - Anixa Biosciences Inc
IEX Last Trade
2.53
0 0%
Share volume: 5
Last Updated: Fri 27 Dec 2024 07:52:24 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$2.53
0.00
0.00%
Fundamental analysis
22%
Profitability
25%
Dept financing
5%
Liquidity
50%
Performance
16%
Performance
5 Days
-0.39%
1 Month
-22.36%
3 Months
-19.44%
6 Months
7.98%
1 Year
-34.77%
2 Year
-34.61%
Key data
Stock price
$2.53
DAY RANGE
$2.53 - $2.53
52 WEEK RANGE
$2.25 - $5.13
52 WEEK CHANGE
-$33.76
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
09/06/2024
Company detail
CEO: Amit D. Kumar
Region: US
Website: anixa.com
Employees: 5
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: anixa.com
Employees: 5
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Anixa Biosciences, Inc. develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company is also developing immuno-therapy drugs against cancer.
Recent news